CV Sciences, Inc. Positioned to Participate in the Medicare and Medicaid Pilot Program for CBD
Private Wellness Club Continuum Unlocks Final Membership Tier at West Village Flagship
Ginkgo Bioworks Partners with Carnegie-Mellon University to Develop Innovative New Cancer Screening Approach
KLAS Report Shows Strong Early Results for TrustCommerce Cloud Payments
BioFlorida Announces Appointment of Dr. Anthony Japour, CEO of iTolerance, Inc., as Chair of the Southeast Chapter
NEWTON, Mass., Dec. 01, 2020 (GLOBE NEWSWIRE) -- Allena Pharmaceuticals, Inc. (NASDAQ: ALNA), a late-stage, biopharmaceutical company dedicated to developing...
Mariann Byerwalter Mariann Byerwalter joins Scipher Medicine’s Board of Advisors WALTHAM, Mass., Dec. 01, 2020 (GLOBE NEWSWIRE) -- Scipher Medicine,...
Call to be held Wednesday, December 9, 2020, at 1:00 p.m. ESTWORCESTER, Mass., Dec. 01, 2020 (GLOBE NEWSWIRE) -- Mustang...
Former CEO and Antios co-founder, Abel De La Rosa, Ph.D., appointed Chairman of the Board of Directors Mayes to lead...
$10 million funded immediately$25 million available upon TreT FDA approvalInterest-only period extended to September 2022WESTLAKE VILLAGE, Calif., Dec. 01, 2020...
Required lab testing complete for Biotres a novel holter patch productREDWOOD CITY, Calif., Dec. 01, 2020 (GLOBE NEWSWIRE) -- Biotricity...
BOISE, Idaho, Dec. 01, 2020 (GLOBE NEWSWIRE) -- Healthwise, a leader in evidence-based health education, technology, and services, announced today...
ZILXI is the First FDA Approved Minocycline Product for the Treatment of Inflammatory Lesions of Rosacea in AdultsZILXI demonstrated a favorable safety and tolerability profile for...
BASKING RIDGE, N.J., Dec. 01, 2020 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine company, announced today that...
SAN FRANCISCO, Dec. 01, 2020 (GLOBE NEWSWIRE) -- FibroGen, Inc. (NASDAQ: FGEN) today announced the retirement of K. Peony Yu,...
IJSS-published review finds that the novel biplanar expandable cage provides effective vertebral body slip or spondylolisthesis reduction and improvement in...
New objective response in colon cancer triggers trial expansionLEXINGTON, Mass., Dec. 01, 2020 (GLOBE NEWSWIRE) -- Agenus Inc. (NASDAQ: AGEN),...
New long-term safety, efficacy, and durability data for FINTEPLA® (fenfluramine) oral solution in Dravet syndromeFull results from Phase 3 study...
NORCROSS, Ga., Dec. 01, 2020 (GLOBE NEWSWIRE) -- Galectin Therapeutics Inc. (NASDAQ:GALT), the leading developer of therapeutics that target galectin...
Prospective study published in Journal of the American Academy of Dermatology BOCA RATON, Dec. 01, 2020 (GLOBE NEWSWIRE) -- Sensus...
HST-001 Demonstrated Separation from Placebo at Week 18 Primary Efficacy Endpoint Assessment HST-001 Found to be Safe and Well Tolerated...
VALENCIA, Calif, and MELBOURNE, Australia, Dec. 01, 2020 (GLOBE NEWSWIRE) -- AVITA Therapeutics, Inc. (NASDAQ: RCEL, ASX:AVH), a regenerative medicine...
• Application accepted under Priority Review designation• Application accepted into Real Time Oncology Review (RTOR) pilot program• This is BridgeBio’s second NDA...
BOCA RATON, Fla., Dec. 01, 2020 (GLOBE NEWSWIRE) -- Jushi Holdings Inc. (“Jushi” or the “Company”) (CSE: JUSH) (OTCMKTS: JUSHF),...
TORONTO, Dec. 01, 2020 (GLOBE NEWSWIRE) -- VitalHub Corp. (the “Company” or “VitalHub”) (TSXV: VHI) is pleased to announce that...
